Esticast Logo
Get In Touch!

Global Human Growth Hormone Market, By Application (Growth Hormone Deficiency, Turner Syndrome, Prader-Willi Syndrome, Other), By Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Online Pharmacy, Other), Estimation & Forecast, 2019 – 2026

Global Human Growth Hormone Market is estimated to reach $4.9 billion in 2019 with a CAGR of 8.5% from 2019 to 2026.

Market Definition

Global human growth hormone market is estimated to reach $4.9 billion in 2019 with a CAGR of 8.5% from 2019 to 2026. Human growth hormone is a peptide hormone produced by the pituitary gland. It is also known as somatotropin. Growth hormone plays an important role in body composition, growth, cell metabolism, and cell repair. Growth hormone (GH) deficiency is caused in humans when the pituitary gland is unable to synthesize adequate concentration of human growth hormone. Human GH is available as prescription drug which is administered by injection.

Industry Dynamics

The rising prevalence of diseases related to growth hormone is one of the key factors catalyzing market growth. As per the data published by Medscape, in the U.S., about 6,000 adults are diagnosed with growth hormone deficiency (GHD) yearly. Strong product pipeline and ongoing R&D activities for the development of novel growth hormone products is anticipated to contribute to the market growth. Prominent market players such as Ascendis Pharma A/S, Eli Lily and Company, Ferring Pharmaceuticals, Teva Pharmaceutical Industries Pvt Ltd. and Sanofi S.A. are engaged in R&D activities for the development of new growth hormone formulations.  For instance, in May 2019, Ascendis Pharma A/S stated the preliminary findings from the phase III fliGHt Trial of TransCon Growth Hormone (hGH). The findings implied that Moreover, the initiatives take by the public and private organizations to increase awareness about growth hormone deficiencies and treatment is anticipated to boost the growth of the market. Despite the drivers, the high cost associated with human growth hormone therapies and several adverse effects related to human growth hormone may negatively affect the market growth over the forecast period.

Market Segmentation

The global human growth hormone market has been divided into application and distribution channel. The application segment has been divided into growth hormone deficiency, idiopathic short stature, turner syndrome, prader-willi syndrome, small for gestational age (SGA), and others. The growth hormone deficiency segment has been sub-segmented into pediatric growth hormone deficiency and adult growth hormone deficiency. By distribution channel, the global market has been segmented into retail pharmacy, hospital pharmacy, specialty pharmacy, and online pharmacy.

Regional Analysis

On a regional basis, the global human growth hormone market has been divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America has been classified into the U.S. and Canada. Europe region has been classified into the UK, France, Germany, Italy, and Rest of Europe. Asia-Pacific region has been divided into Japan, India, South Korea, China, and Rest of Asia-Pacific. Furthermore, the South America region has been segmented into Brazil, Mexico, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Africa, and the Rest of the Middle East.  North America is the dominating region in the global market. The market growth in the region can be attributed to the well-established healthcare sector, favorable government initiatives for rare diseases, and suitable reimbursement scenario. In addition, the presence of prominent market players such as Pfizer Inc., Genentech Inc., and Eli Lily and Company supports the market in the region. Moreover, Asia Pacific region is anticipated to witness significant growth over the assessment period. Factors such developing healthcare infrastructure, growing awareness about rare diseases, and increasing healthcare expenditure in countries such as India and China is expected to contribute to the market growth in the region.

Key Players

Key players operating in the human growth hormone industry include Pfizer, Inc., Novo Nordisk A/S, Sandoz International GmbH (Novartis AG), Eli Lilly and Company, Merck KGaA, Genentech, Inc. (Roche), Teva Pharmaceutical Industries, Ltd, Ascendis Pharma A/S, and Ferring Pharmaceuticals. The prominent companies functioning in the market are undertaking key strategies such as partnerships, product development, mergers, and acquisitions for geographical expansion as well as to strengthen their market presence. For instance, in October 2019, OPKO Health Inc. and Pfizer Inc. stated that the Phase III trial assessing treatment with somatrogon medicated weekly once in pre-pubertal children having growth hormone deficiency achieved its primary endpoint of non-inferiority to GENOTROPIN  dosed daily once in regard to the height velocity of 12 months of treatment. Similarly, in November 2018, Novo Nordisk A/S and Strongbridge Biopharma plc entered into an agreement to obtain the U.S. and Canadian rights to Macrilen. Macrilen (macimorelin), the only FDA approved oral product indicated for the diagnosis of Adult Growth Hormone Deficiency. In addition, Macrilen was granted orphan drug exclusivity by the FDA in the U.S.

Human Growth Hormone Market Key Segments:

By Application
  • Growth Hormone Deficiency
    • Pediatric Growth Hormone Deficiency
    • Adult Growth Hormone Deficiency
  • Idiopathic Short Stature
  • Turner Syndrome
  • Prader-Willi Syndrome
  • Small For Gestational Age (SGA)
  • Others
By Distribution Channel
  • Retail Pharmacy
  • Hospital Pharmacy
  • Specialty Pharmacy
  • Online Pharmacy
By Geography
  • North America
    • The U.S.
    • Canada
  • Europe
    • U.K
    • Germany
    • France
    • Italy
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Mexico
    • Rest of South America
  • Middle East & Africa
    • GCC Countries
    • Egypt
    • South Africa
    • Rest of Middle East & Africa

Frequently Asked Questions (FAQ):

What countries in the Asia Pacific are supposed to hold substantial share in the global human growth hormone market? -The key countries accounting substantial market share in the Asia Pacific region are India, China, Japan, and South Korea. What is the anticipated CAGR of the market during the assessment period? -The market is expected to register a CAGR of 8.5% between 2019 and 2026. Who are the key players in the global market? -The key players in the global market include Genentech, Inc. (Roche), Novo Nordisk A/S, Sandoz International GmbH (Novartis AG), Pfizer, Inc., Eli Lilly and Company, and Merck KGaA, among others. What are the key segments in the global human growth hormone market? - The global human growth hormone market has been segmented into application and distribution

Table of Content 1. Market Introduction 1.1. Executive Summary 1.2. Market Definition 1.3. Market Scope 2. Research Methodology 2.1. Primary Research 2.2. Research Methodology 2.3. Assumptions & Exclusions 2.4. Secondary data sources 3. Global Human Growth Hormone Market Overview 3.1. Report Segmentation & Scope 3.2. Key Market Trend 3.3. Drivers 3.4. Restraints 3.5. Opportunities 3.6. Porter’s Five Forces Analysis 3.6.1. Porter’s Five Forces Analysis 3.7. Market Share Analysis 4. Global Human Growth Hormone Market, By Application 4.1. Overview 4.2. Growth Hormone Deficiency 4.2.1. Pediatric Growth Hormone Deficiency 4.2.1.1. Market Size & Forecast, 2019-2026 4.2.2. Adult Growth Hormone Deficiency 4.2.2.1. Market Size & Forecast, 2019-2026 4.3. Idiopathic Short Stature 4.3.1. Market Size & Forecast, 2019-2026 4.4. Turner Syndrome 4.4.1. Market Size & Forecast, 2019-2026 4.5. Prader-Willi Syndrome 4.5.1. Market Size & Forecast, 2019-2026 4.6. Small For Gestational Age (SGA) 4.6.1. Market Size & Forecast, 2019-2026 4.3. Others 5. Global Human Growth Hormone Market, By Distribution Channel 5.1. Overview 5.2. Retail Pharmacy 5.2.1 Market Size & Forecast, 2019-2026 5.3. Hospital Pharmacy 5.3.1 Market Size & Forecast, 2019-2026 5.4. Specialty Pharmacy 5.4.1 Market Size & Forecast, 2019-2026 5.5. Online Pharmacy 5.5.1 Market Size & Forecast, 2019-2026 6. Global Human Growth Hormone Market, Region 6.1. Overview 6.1.1. Global Market Size & Forecast, 2017-2026 6.2. North America Human Growth Hormone Market 6.2.1. North America Market Size & Forecast, 2019-2026, By Country 6.2.2. North America Market Size & Forecast, 2019-2026, By Application 6.2.3. North America Market Size & Forecast, 2019-2026, By Distribution Channel 6.2.4. U.S. 6.2.4.1. Market Size and Forecast, 2019-2026 6.2.5. Canada 6.2.5 .1. Market Size and Forecast, 2019-2026 6.3. Europe Human Growth Hormone Market 6.3.1. Europe Market Size & Forecast, 2019-2026, By Country 6.3.2. Europe Market Size & Forecast, 2019-2026, By Application 6.2.3. Europe Market Size & Forecast, 2019-2026, By Distribution Channel 6.3.4. Germany 6.3.4.1. Market Size and Forecast, 2019-2026 6.3.5. France 6.3.5.1. Market Size and Forecast, 2019-2026 6.3.6. UK 6.3.6.1. Market Size and Forecast, 2019-2026 6.3.7. Italy 6.3.7.1. Market Size and Forecast, 2019-2026 6.3.8. Spain 6.3.8.1. Market Size and Forecast, 2019-2026 6.3.9. Rest of Europe 6.3.9.1. Market Size and Forecast, 2019-2026 6.4. Asia-Pacific Human Growth Hormone Market 6.4.1. Asia-Pacific Market Size & Forecast, 2019-2026, By Country 6.4.2. Asia-Pacific Market Size & Forecast, 2019-2026, By Application 6.2.3. Asia-Pacific Market Size & Forecast, 2019-2026, By Distribution Channel 6.4.4. Japan 6.4.4.1. Market Size and Forecast, 2019-2026 6.4.5. China 6.4.5.1. Market Size and Forecast, 2019-2026 6.4.6. Australia 6.4.6.1. Market Size and Forecast, 2019-2026 6.4.7. India 6.4.7.1. Market Size and Forecast, 2019-2026 6.4.8. South Korea 6.4.8.1. Market Size and Forecast, 2019-2026 6.4.9. Rest of Asia-Pacific 6.4.9.1. Market Size and Forecast, 2019-2026 6.5. South America Human Growth Hormone Market 6.5.1. South America Market Size & Forecast, 2019-2026, By Country 6.5.2. South America Market Size & Forecast, 2019-2026, By Application 6.5.3. South America Market Size & Forecast, 2019-2026, By Distribution Channel 6.5.4. Brazil 6.5.4.1. Market Size and Forecast, 2019-2026 6.5.5. Argentina 6.5.5.1. Market Size and Forecast, 2019-2026 6.5.6. Rest of South America 6.5.6.1. Market Size and Forecast, 2019-2026 6.6. Middle East & Africa Human Growth Hormone Market 6.6.1. Middle East & Africa Market Size & Forecast, 2019-2026, By Country 6.6.2. Middle East & Africa Market Size & Forecast, 2019-2026, By Application 6.2.3. Middle East & Africa Market Size & Forecast, 2019-2026, By Distribution Channel 6.6.4. GCC Countries 6.6.4.1. Market Size and Forecast, 2019-2026 6.6.5. Egypt 6.6.5.1. Market Size and Forecast, 2019-2026 6.6.6. South Africa 6.6.6.1. Market Size and Forecast, 2019-2026 6.6.7. Rest of Middle East & Africa 6.6.7.1. Market Size and Forecast, 2019-2026 7. Company Profile 7.1. Pfizer, Inc. 7.1.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.1.2. Product, Type, Category, Product, and Specification 7.1.3. Financial Performance 7.1.4. Strategic Initiatives 7.2. Novo Nordisk A/S 7.3. Sandoz International GmbH (Novartis AG) 7.4. Eli Lilly and Company 7.5. Merck KGaA 7.6. Genentech, Inc. (Roche) 7.7. Teva Pharmaceutical Industries, Ltd 7.7. Ascendis Pharma A/S 7.9 Ferring Pharmaceuticals. 8. List of Tables Table 1 Global Human Growth Hormone Market Share, By Application, 2016-2026 ($Million) Table 2 Growth Hormone Deficiency, Human Growth Hormone Market Share, By Region, 2016-2026 ($Million) Table 3 Pediatric Growth Hormone Deficiency, Human Growth Hormone Market Share, By Region, 2016-2026 ($Million) Table 4 Adult Growth Hormone Deficiency, Human Growth Hormone Market Share, By Region, 2016-2026 ($Million) Table 5 Idiopathic Short Stature, Human Growth Hormone Market Share, By Region, 2016-2026 ($Million) Table 6 Turner Syndrome, Human Growth Hormone Market Share, By Region, 2016-2026 ($Million) Table 7 Prader-Willi Syndrome, Human Growth Hormone Market Share, By Region, 2016-2026 ($Million) Table 8 Small For Gestational Age (SGA), Human Growth Hormone Market Share, By Region, 2016-2026 ($Million) Table 9 Others, Human Growth Hormone Market Share, By Region, 2016-2026 ($Million) Table 10 Global Human Growth Hormone Market Share, By Distribution Channel, 2016-2026 ($Million) Table 11 Retail Pharmacy, Human Growth Hormone Market Share, By Region, 2016-2026 ($Million) Table 12 Hospital Pharmacy, Human Growth Hormone Market Share, By Region, 2016-2026 ($Million) Table 13 Specialty Pharmacy, Human Growth Hormone Market Share, By Region, 2016-2026 ($Million) Table 14 Online Pharmacy, Human Growth Hormone Market Share, By Region, 2016-2026 ($Million) Table 15 Global Human Growth Hormone Market Value, 2016-2026 ($Million) Table 16 North America, Human Growth Hormone Market Value and Growth Rate, 2016-2026 ($Million) Table 17 North America, Human Growth Hormone Market Share Value, By Country, 2016-2026 ($Million) Table 18 North America Human Growth Hormone Market Share Value, By Application, 2016-2026 ($Million) Table 19 North America Human Growth Hormone Market Share Value, By Distribution Channel, 2016-2026 ($Million) Table 20 Europe Human Growth Hormone Market Value and Growth Rate, 2016-2026 ($Million) Table 21 Europe Human Growth Hormone Market Share Value, By Country, 2016-2026 ($Million) Table 22 Europe Human Growth Hormone Market Share Value, By Application, 2016-2026 ($Million) Table 23 Europe Human Growth Hormone Market Share Value, By Distribution Channel, 2016-2026 ($Million) Table 24 Asia Pacific Human Growth Hormone Market Value and Growth Rate, 2016-2026 ($Million) Table 25 Asia Pacific Human Growth Hormone Market Share Value, By Country, 2016-2026 ($Million) Table 26 Asia Pacific Human Growth Hormone Market Share Value, By Application, 2016-2026 ($Million) Table 27 Asia Pacific Human Growth Hormone Market Share Value, By Distribution Channel, 2016-2026 ($Million) Table 28 South America Human Growth Hormone Market Value and Growth Rate, 2016-2026 ($Million) Table 29 South America Human Growth Hormone Market Share Value, By Country, 2016-2026 ($Million) Table 30 South America Human Growth Hormone Market Share Value, By Application, 2016-2026 ($Million) Table 31 South America Human Growth Hormone Market Share Value, By Distribution Channel, 2016-2026 ($Million) Table 32 Middle East & Africa Human Growth Hormone Market Value and Growth Rate, 2016-2026 ($Million) Table 33 Middle East & Africa Human Growth Hormone Market Share Value, By Country, 2016-2026 ($Million) Table 34 Middle East & Africa Human Growth Hormone Market Share Value, By Application, 2016-2026 ($Million) Table 35 Middle East & Africa Human Growth Hormone Market Share Value, By Distribution Channel, 2016-2026 ($Million) Table 36 Recent Developments 9. List of Figures Figure 1 Global Human Growth Hormone Market Overview Figure 2 Global Human Growth Hormone Market Segmentation Figure 3 Global Human Growth Hormone Market Drivers Figure 4 Global Human Growth Hormone Market Restrains Figure 5 Global Human Growth Hormone Market Porter’s Analysis Figure 6 Global Human Growth Hormone Market share, By Application, 2018 VS 2026 (%) Figure 7 Global Human Growth Hormone Market share, By Distribution Channel, 2018 VS 2026 (%) Figure 8 U.S. Human Growth Hormone Market share, 2016-2026 ($Million) Figure 9 Canada Human Growth Hormone Market share, 2016-2026 ($Million) Figure 10 U.K. Human Growth Hormone Market share, 2016-2026 ($Million) Figure 11 Germany Human Growth Hormone Market share, 2016-2026 ($Million) Figure 12 France Human Growth Hormone Market share, 2016-2026 ($Million) Figure 13 Italy Human Growth Hormone Market share, 2016-2026 ($Million) Figure 14 Rest of Europe Human Growth Hormone Market share, 2016-2026 ($Million) Figure 15 India Human Growth Hormone Market share, 2016-2026 ($Million) Figure 16 China Human Growth Hormone Market share, 2016-2026 ($Million) Figure 17 Japan Human Growth Hormone Market share, 2016-2026 ($Million) Figure 18 South Korea Human Growth Hormone Market share, 2016-2026 ($Million) Figure 19 Rest of Asia Pacific Human Growth Hormone Market share, 2016-2026 ($Million) Figure 20 Brazil Human Growth Hormone Market share, 2016-2026 ($Million) Figure 21 Argentina Human Growth Hormone Market share, 2016-2026 ($Million) Figure 22 Rest of South America Human Growth Hormone Market share, 2016-2026 ($Million) Figure 23 GCC Countries Human Growth Hormone Market share, 2016-2026 ($Million) Figure 24 Egypt Human Growth Hormone Market share, 2016-2026 ($Million) Figure 25 South Africa Human Growth Hormone Market share, 2016-2026 ($Million) Figure 26 Rest of Middle East & Africa Human Growth Hormone Market share, 2016-2026 ($Million)

  • Pfizer, Inc
  • Novo Nordisk A/S
  • Sandoz International GmbH (Novartis AG)
  • Eli Lilly and Company
  • Merck KGaA
  • Genentech, Inc. (Roche)
  • Teva Pharmaceutical Industries Ltd
  • Ascendis Pharma A/S
  • Ferring Pharmaceuticals

Select License Type

  • $4700
  • $5600
  • $2000
  • Buy Now

Report Highlights:

Complete overview of market
Major drivers, restrain, opportunities, and challenges of the market
Market Trends and how they are boosting the market growth
Changing dynamics in the Market
Complete overview of the market
Historical, Base year, projected, and current market size in terms of value and volume
COVID-19 Impact analysis of the market
Current industry trends and developments

CLIENTS

Esticast Logo

CORPORATE OFFICE

location  (US)

1055 West 7th Street, Los Angeles, CA 90017 (P) US

phone  +1-213-262-0704
location  (APAC Address)

Office No. 407, Navale Icon IT Park, Near Navale Bridge, Narhe, Pune, Maharashtra 411041

phone  +91-959-503-5024

COMPANY

SECURE ONLINE PAYMENTS

  • visa
  • mastercard
  • amex
  • discover

FOLLOW US

  • facebook
  • linkedin
  • phone
  • youtube
© 2022 | All Rights Reserved by Esticast Research & Consulting